View prices & discounts
Free gifts
Request & accept offers online
Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Human Melanoma-associated antigen 1 (MAGEA1) | Login | Recombinant Human Melanoma-associated antigen 1 (MAGEA1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Melanoma-associated antigen 1 (MAGEA1) | Login | Recombinant Human Melanoma-associated antigen 1 (MAGEA1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Polypyrimidine tract-binding protein 1 (PTBP1) | Login | Recombinant Human Polypyrimidine tract-binding protein 1 (PTBP1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Blood group Rh (D) polypeptide (RHD), partial | Login | Recombinant Human Blood group Rh (D) polypeptide (RHD), partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Thymic stromal lymphopoietin (TSLP) | Login | Recombinant Human Thymic stromal lymphopoietin (TSLP) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Legumain(LGMN) | Login | Recombinant Human Legumain(LGMN) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Legumain(LGMN) | Login | Recombinant Human Legumain(LGMN) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Legumain(LGMN) | Login | Recombinant Human Legumain(LGMN) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Polypyrimidine tract-binding protein 1(PTBP1) | Login | Recombinant Human Polypyrimidine tract-binding protein 1(PTBP1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Macaca fascicularis Trophoblast glycoprotein(TPBG),partial | Login | Recombinant Macaca fascicularis Trophoblast glycoprotein(TPBG),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Blood group Rh(D) polypeptide(RHD),partial | Login | Recombinant Human Blood group Rh(D) polypeptide(RHD),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human T-cell antigen CD7(CD7),partial | Login | Recombinant Human T-cell antigen CD7(CD7),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human CD81 antigen(CD81),partial | Login | Recombinant Human CD81 antigen(CD81),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Tyrosine-protein phosphatase non-receptor type substrate 1(SIRPA),partial | Login | Recombinant Human Tyrosine-protein phosphatase non-receptor type substrate 1(SIRPA),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Heat-stable enterotoxin receptor(GUCY2C),partial | Login | Recombinant Human Heat-stable enterotoxin receptor(GUCY2C),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human B-cell receptor CD22(CD22),partial (Active) | Login | Recombinant Human B-cell receptor CD22(CD22),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Epidermal growth factor receptor(EGFR),partial (Active) | Login | Recombinant Human Epidermal growth factor receptor(EGFR),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Heat-stable enterotoxin receptor(GUCY2C),partial | Login | Recombinant Human Heat-stable enterotoxin receptor(GUCY2C),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human B-cell receptor CD22(CD22),partial (Active) | Login | Recombinant Human B-cell receptor CD22(CD22),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Epidermal growth factor receptor(EGFR),partial (Active) | Login | Recombinant Human Epidermal growth factor receptor(EGFR),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Tumor-associated calcium signal transducer 2(TACSTD2),partial (Active) | Login | Recombinant Human Tumor-associated calcium signal transducer 2(TACSTD2),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Mesothelin(MSLN),partial (Active) | Login | Recombinant Human Mesothelin(MSLN),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Ephrin type-A receptor 3(EPHA3),partial (Active) | Login | Recombinant Human Ephrin type-A receptor 3(EPHA3),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Mesothelin(MSLN),partial (Active) | Login | Recombinant Human Mesothelin(MSLN),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Ephrin type-A receptor 3(EPHA3),partial (Active) | Login | Recombinant Human Ephrin type-A receptor 3(EPHA3),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
Contact
Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
50823 Cologne
Germany
T +49 221 126 02 66
F +49 221 126 02 67
